JP2005505605A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005505605A5 JP2005505605A5 JP2003535798A JP2003535798A JP2005505605A5 JP 2005505605 A5 JP2005505605 A5 JP 2005505605A5 JP 2003535798 A JP2003535798 A JP 2003535798A JP 2003535798 A JP2003535798 A JP 2003535798A JP 2005505605 A5 JP2005505605 A5 JP 2005505605A5
- Authority
- JP
- Japan
- Prior art keywords
- rosuvastatin
- medicament
- patient
- risk
- dementia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010012289 Dementia Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 claims 2
- 229960000672 rosuvastatin Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103509A SE0103509D0 (sv) | 2001-10-19 | 2001-10-19 | Rosuvastatin in pre demented states |
| PCT/SE2002/001911 WO2003032995A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005505605A JP2005505605A (ja) | 2005-02-24 |
| JP2005505605A5 true JP2005505605A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
Family
ID=20285721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003535798A Pending JP2005505605A (ja) | 2001-10-19 | 2002-10-18 | 前痴呆状態におけるロスバスタチン |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060229321A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1446123A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005505605A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20040058201A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1604780A (cg-RX-API-DMAC7.html) |
| AR (1) | AR036891A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0213434A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2463597A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO5580773A2 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0401798A3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL161380A0 (cg-RX-API-DMAC7.html) |
| IS (1) | IS7218A (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04003631A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20041840L (cg-RX-API-DMAC7.html) |
| PL (1) | PL369573A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2004112422A (cg-RX-API-DMAC7.html) |
| SE (1) | SE0103509D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003032995A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200402844B (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2537271A1 (en) | 2003-08-28 | 2005-03-17 | Teva Pharmaceutical Industries, Ltd. | Process for preparation of rosuvastatin calcium |
| GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
| US7777034B2 (en) | 2003-11-24 | 2010-08-17 | Teva Pharmaceutical Industries Ltd. | Crystalline ammonium salts of rosuvastatin |
| CN1894221B (zh) | 2003-12-02 | 2012-08-08 | 特瓦制药工业有限公司 | 用于表征罗苏伐他汀的参照标准品 |
| US7179916B2 (en) | 2004-07-13 | 2007-02-20 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of rosuvastatin |
| CA2680693A1 (en) | 2005-02-22 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Preparation of rosuvastatin |
| WO2007022488A2 (en) | 2005-08-16 | 2007-02-22 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
| WO2012073256A1 (en) | 2010-11-29 | 2012-06-07 | Cadila Healthcare Limited | Salts of rosuvastatin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US7189703B2 (en) * | 1998-01-09 | 2007-03-13 | Intracell, Llc | Treatment and diagnosis of alzheimer's disease |
| AR022462A1 (es) * | 1999-02-06 | 2002-09-04 | Astrazeneca Uk Ltd | Uso de un agente que disminuye el colesterol |
| US20030100493A1 (en) * | 2001-07-19 | 2003-05-29 | Sol Weiss | Sublingual use of inhibitors in the biosynthesis of cholesterol |
-
2001
- 2001-10-19 SE SE0103509A patent/SE0103509D0/xx unknown
-
2002
- 2002-10-17 AR ARP020103895A patent/AR036891A1/es not_active Application Discontinuation
- 2002-10-18 US US10/492,971 patent/US20060229321A1/en not_active Abandoned
- 2002-10-18 CA CA002463597A patent/CA2463597A1/en not_active Abandoned
- 2002-10-18 IL IL16138002A patent/IL161380A0/xx unknown
- 2002-10-18 PL PL02369573A patent/PL369573A1/xx not_active Application Discontinuation
- 2002-10-18 JP JP2003535798A patent/JP2005505605A/ja active Pending
- 2002-10-18 KR KR10-2004-7005585A patent/KR20040058201A/ko not_active Withdrawn
- 2002-10-18 BR BR0213434-9A patent/BR0213434A/pt not_active Application Discontinuation
- 2002-10-18 HU HU0401798A patent/HUP0401798A3/hu unknown
- 2002-10-18 CN CNA028253477A patent/CN1604780A/zh active Pending
- 2002-10-18 MX MXPA04003631A patent/MXPA04003631A/es not_active Application Discontinuation
- 2002-10-18 EP EP02783893A patent/EP1446123A1/en not_active Withdrawn
- 2002-10-18 WO PCT/SE2002/001911 patent/WO2003032995A1/en not_active Ceased
- 2002-10-18 RU RU2004112422/14A patent/RU2004112422A/ru not_active Application Discontinuation
-
2004
- 2004-04-13 IS IS7218A patent/IS7218A/is unknown
- 2004-04-15 ZA ZA200402844A patent/ZA200402844B/en unknown
- 2004-04-19 CO CO04035705A patent/CO5580773A2/es not_active Application Discontinuation
- 2004-05-05 NO NO20041840A patent/NO20041840L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME02688B (me) | Hinazolinoni kao inhibitori humane fosfatidilinozitol 3 - kinaze delta | |
| IL190150A0 (en) | New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease | |
| JP2005500357A5 (cg-RX-API-DMAC7.html) | ||
| EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
| DE60030844D1 (de) | Kombinationen von formoterol und tiotropium-salz | |
| IL205262A (en) | Use of Risderdone Acid or its Pharmaceutical Salt to produce oral medication once a month for the prevention and treatment of osteoporosis | |
| EP1635762A4 (en) | LOW-DOSED PHARMACEUTICAL POWDER FOR INHALATION | |
| NO2014032I2 (no) | Kombinasjon av rilpivirin eller et farmasøytisk akseptabelt salt av rilpivirin, medregnet hydrokloridsaltet av rilpivirin, emtricitabin og tenofovir, spesielt tenofovir disoproksil eller tenofovirdisoproksilfumarat. | |
| GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
| AU2003259381A8 (en) | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases | |
| NO20065904L (no) | Terapeutiske forbindelser | |
| EP1558214A4 (en) | MICROEMULSION CONCENTRATES FOR THE ORAL ADMINISTRATION OF WATER-INSOLICED MEDICAMENT AGAINST COLLECTIONS AND METHOD OF PREPARATION THEREOF | |
| DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| DK1383752T3 (da) | Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser | |
| TW200624431A (en) | Phthalazinone derivatives, their manufacture and use as pharmaceutical agents | |
| JP2003526626A5 (cg-RX-API-DMAC7.html) | ||
| JP2008513510A5 (cg-RX-API-DMAC7.html) | ||
| JP2005508963A5 (cg-RX-API-DMAC7.html) | ||
| JP2005505605A5 (cg-RX-API-DMAC7.html) | ||
| RU2004112422A (ru) | Роувастатин в преддеменционных состояниях | |
| EA200701181A1 (ru) | Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний | |
| CA2496476A1 (en) | Therapeutic use | |
| NO20043483L (no) | Anvendelse av melagatran for fremstilling av et medikament for behandling av type 1 Diabetes mellitus | |
| BR0009080A (pt) | Método de tratamento da apnéia do sono | |
| FR2848817B1 (fr) | Matelas therapeutique tricouches pour patients obeses |